Key Points
• PMI has begun production at a $600 million, 600,000-square-foot ZYN facility in Aurora, Colorado.
• The plant is expected to employ 500 workers and represents PMI’s second U.S. ZYN manufacturing site.
• ZYN sales have grown at triple-digit rates, driving the need for expanded domestic production capacity.
• State and local authorities approved financial incentives as the project is expected to generate significant economic impact.
2Firsts, February 21, 2026
According to The Denver Post, Philip Morris International has commenced mass production of ZYN nicotine pouches at a newly developed manufacturing facility in Aurora, Colorado.
The 600,000-square-foot plant represents a $600 million capital investment by PMI through its Swedish Match subsidiary. The facility is one of three ZYN production sites in the United States and follows the company’s Owensboro, Kentucky, plant.
Approximately 120 employees have been hired as production ramps up, with total employment expected to reach 500 positions. Average annual wages are projected at $90,000. The site is designed with largely automated production lines, where nicotine is blended with plant-based fillers and flavorings before being portioned, weighed, sealed and packaged through high-speed machinery.
Wendy Mitchell, president and CEO of the Aurora Economic Development Council, said the project is expected to generate approximately $550 million in annual economic benefits and support around 1,000 indirect jobs beyond the 500 direct positions. Aurora approved $7.1 million in tax rebates for PMI, while the Colorado Economic Development Commission and Adams County also approved incentives.
Construction and commissioning are progressing in phases, with around 800 construction workers involved in completing remaining sections of the plant. PMI said the expansion was driven by strong demand growth, with ZYN sales increasing at triple-digit rates in recent years and the brand estimated to hold 70% to 80% of the U.S. nicotine pouch market.
Aurora approved $7.1 million in tax rebates, while the Colorado Economic Development Commission authorized $4.5 million in job growth tax credits and Adams County approved additional incentives. Local officials estimate the facility could generate approximately $550 million in annual economic benefits and support around 1,000 indirect jobs.
In January 2025, the U.S. Food and Drug Administration authorized ZYN as the first nicotine pouch cleared for marketing in the United States, stating it is “appropriate for the protection of public health,” though not formally approved.
PMI said it requires retailers to verify buyer age and conducts compliance checks to ensure adherence to federal and state regulations.
(cover image source: The Denver Pos)
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
